Shape Therapeutics promotes Lisa Taylor Ash to general counsel
Shape Therapeutics, a biotechnology company developing RNA technologies to shape the future of gene therapy, has promoted their vice president and head of legal Lisa Taylor Ash (pictured) to the role of general counsel.
Taylor Ash joined Shape in November of 2019 from Juno Therapeutics, where she was vice president and head of healthcare law and compliance. Prior to that, Taylor Ash served as senior director for commercial legal affairs & compliance for Exelixis and as corporate counsel specializing in healthcare law at Pharmacyclics. Taylor Ash started her career practicing law at Sidley Austin law firm.